KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Encompass Health (EHC) Income towards Parent Company (2016 - 2026)

Encompass Health (EHC) has disclosed Income towards Parent Company for 18 consecutive years, with $15.9 million as the latest value for Q1 2026.

  • For Q1 2026, Income towards Parent Company rose 3280.0% year-over-year to $15.9 million; the TTM value through Mar 2026 reached $15.4 million, up 870.0%, while the annual FY2025 figure was -$1.0 million, 64.29% up from the prior year.
  • Income towards Parent Company hit $15.9 million in Q1 2026 for Encompass Health, up from $800000.0 in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $23.7 million in Q1 2022 and bottomed at -$18.5 million in Q3 2022.
  • Average Income towards Parent Company over 5 years is $900000.0, with a median of -$900000.0 recorded in 2025.
  • Year-over-year, Income towards Parent Company crashed 466.67% in 2023 and then soared 3280.0% in 2026.
  • Encompass Health's Income towards Parent Company stood at -$1.5 million in 2022, then plummeted by 466.67% to -$8.5 million in 2023, then surged by 104.71% to $400000.0 in 2024, then skyrocketed by 100.0% to $800000.0 in 2025, then soared by 1887.5% to $15.9 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods came in at $15.9 million, $800000.0, and -$400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.